Results 61 to 70 of about 1,015,018 (167)

alpha 1- and beta 2-adrenergic receptor expression in the Madin-Darby canine kidney epithelial cell line. [PDF]

open access: yes, 1983
The Madin-Darby canine kidney (MDCK) cell line, derived from distal tubule/collecting duct, expresses differentiated properties of renal tubule epithelium in culture.
M D Snavely   +9 more
core   +1 more source

Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors.

open access: yes, 1988
The beta 1- and beta 2-adrenergic receptors are two structurally related, but pharmacologically distinguishable, receptor subtypes, both of which activate adenylyl cyclase in a catecholamine-dependent manner through the guanine nucleotide-binding ...
Daniel, KW   +3 more
core   +1 more source

Early detection of nebivolol-induced hepatotoxicity

open access: yesEuropean Journal of Case Reports in Internal Medicine
Introduction: Nebivolol, a third-generation selective beta1-adrenergic receptor antagonist possessing vasodilatory properties, is characterised by a favourable safety profile.
Anna M. Torunova   +2 more
doaj   +1 more source

Cost-effectiveness of glaucoma management with monotherapy medications in Egypt

open access: yesJournal of Advanced Pharmaceutical Technology & Research, 2017
Glaucoma is a serious chronic ophthalmic disease since it causes irreversible visual disability if untreated can lead to blindness. Treatment options include medications (classified into five major classes of drugs which are muscarinic cholinergic ...
Amal Abd-Elaal El-Khamery   +3 more
doaj   +1 more source

Beta-adrenergic stimulation and cAMP mobilize Ca2+ from an IP3-insensitive pool in rat submandibular granular ducts.

open access: yes, 1993
The beta-adrenergic agonist isoproterenol induced an increase in intracellular calcium concentration ([Ca2+]i) in rat submandibular granular ducts that was blocked by beta-adrenergic but not by alpha-adrenergic or muscarinic antagonists.
I. H. Valdez   +5 more
core   +1 more source

Betabloqueador tópico pode determinar resultados inconclusivos no ecocardiograma sob estresse com dobutamina em pacientes com glaucoma Topical betablocker use can result in inconclusive dobutamine stress echocardiography in patients with glaucoma

open access: yesArquivos Brasileiros de Cardiologia, 2007
O ecocardiograma sob estresse com dobutamina é um método bem estabelecido para avaliar doença arterial coronária, cuja sensibilidade tem sido potencializada pela adição de atropina no final do protocolo.
Adriana Cordovil   +7 more
doaj   +1 more source

The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.

open access: yes, 1983
The beta-adrenergic stimulation of adenylate cyclase in membranes from human auricles, ventricles, and fetal heart was compared with the binding properties of beta-adrenergic receptors in human auricles.
De Smet, Jean-Marie   +9 more
core  

Effect of Age on Lymphocyte Beta2-Adrenergic Responsiveness

open access: yes, 1991
Beta-adrenergic receptor agonists and antagonists are among the most widely used classes of agents in the US today. Heterogeneity in pharmacologic response among humans exists.
David R. Rutledge, Joel D. Steinberg
core   +1 more source

Medical treatment of female overactive bladder syndrome and treatment-related effects

open access: yesJournal of the Formosan Medical Association, 2018
The age-adjusted prevalence of overactive bladder syndrome (OAB) in Taiwan is approximately 16.9%. Currently, a variety of treatments are available for female OAB.
Sheng-Mou Hsiao, Ho-Hsiung Lin
doaj   +1 more source

Effects of beta-adrenergic agents in lungs of normal and air-embolized awake sheep

open access: yes, 1988
It is unclear whether beta-adrenergic agonists or antagonists affect lung liquid and protein exchange by changing pulmonary hemodynamics or microvascular leakiness. In 23 unanesthetized, instrumented sheep with long-term lung lymph fistulas, we assessed
P. L. Culver   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy